Short interest for Neutra gives investors a sense of the degree to which investors are betting on the decline of Neutra's stock. Short interest data is updated every two weeks.

Neutra Stock (OTC:NTRR), Short Interest Report

Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.

Cannabis

News

Markets

NTRR

Neutra Corporation (OTCPK:NTRR) announced the execution of a binding letter of intent to acquire Mercury Clinical Research, a privately-owned site management organization (SMO) comprised of a network of physicians conducting clinical trials for pharmaceutical companies.

Neutra To Acquire Private Clinical Research Site Management Organization

Penny Stocks

Neutra Subsidiary VIVIS to Expand into Equipment Leasing and Consulting Market

Neutra Corporation (NTRR) Subsidiary VIVIS to Expand into Equipment Leasing and Consulting Market

Neutra Corp

Neutra pauses Mercury Clinical Research acquisition

Health Care

Press Releases

Neutra Nearing Expansion Into Growing Health, Wellness and Life Sciences Sector

Neutra Announces Strategic and Financial Value Creation Plan

Neutra Reflects on 2023 and Looks Forward to 2024

Neutra